Welcome to our dedicated page for Virtuix Holdings news (Ticker: VTIX), a resource for investors and traders seeking the latest updates and insights on Virtuix Holdings stock.
Virtuix Holdings Inc. (VTIX) news focuses on the company’s AI-driven full-body simulation systems and the commercial path for its Omni product family. Coverage often centers on Omni One, omni-directional treadmill technology, virtual reality entertainment, enterprise deployments, defense training, healthcare applications, robotics references, investor conferences, and quarterly operating results.
Virtuix is newsworthy because its public updates connect one core technology to several distinct use cases. The company describes Omni systems for consumer VR entertainment, but also reports defense applications such as counter-drone training, infantry fireteam training, Virtual Terrain Walk development, and military recreation or training deployments. Healthcare and therapeutic applications, including autism therapy references in company materials, add another category of company-specific coverage.
Common VTIX news themes include earnings releases, order activity, product launches or certifications, military and enterprise announcements, research coverage, auditor or filing schedule updates, and capital structure disclosures. The company’s announcements also discuss its Nasdaq listing, emerging growth company status, and public-company reporting obligations.
Following Virtuix news helps readers track how the company describes adoption of Omni One across consumer, defense, enterprise, healthcare, and research markets. VTIX updates can also provide context for later SEC filings, especially when press releases involve operating results, material agreements, governance changes, or business developments.
Virtuix (VTIX) will host a virtual investor webinar today, September 18, 2026, at 10:00 a.m. Eastern Time.
CEO Jan Goetgeluk will discuss the company’s growth strategy, near-term priorities, and recent commercial developments, including accelerating consumer momentum, expanding defense programs, and a potential strategic acquisition. A recent business update highlighted that Omni One orders are up approximately 3X quarter-to-date versus the same period last year after the June launch of Omni One for Quest with Meta.
The company also reported progress across multiple U.S. Department of Defense programs, repeat Omni One Enterprise orders from Tesla’s Optimus humanoid robot program, and additional enterprise sales to organizations including NASA. Investors can register via the provided Livestorm link and access a replay after the event.
Virtuix Holdings (VTIX) will showcase its Omni One full-body simulation platform and present recent commercial progress to family offices and high-net-worth investors at The Austin Family Office & High Net Worth Conference on September 23, 2026, at Hotel Ella in Austin, Texas.
CFO Thomas McGinnis is scheduled to present at 9:40 a.m. CT, with Omni One available for live demonstrations throughout the day. The event follows growing adoption of Omni One, including strong order growth since the launch of Omni One for Quest with Meta, deployments in humanoid robotics with Tesla and Figure AI, counter-drone training systems for the U.S. military, and use in therapy and rehabilitation with universities and clinical partners. Virtuix most recently reported quarterly revenue ahead of analyst estimates.
Virtuix (VTIX) will host a virtual investor webinar on Friday, September 18, 2026, at 10:00 a.m. Eastern Time.
CEO Jan Goetgeluk will discuss the company’s growth strategy, near-term priorities, and recent commercial developments, including accelerating consumer momentum, expanding defense programs, and a potential strategic acquisition. Virtuix reports that Omni One orders are up approximately 3X quarter-to-date versus the same period last year, following the June launch of Omni One for Quest in collaboration with Meta. The company also cites progress across multiple U.S. Department of Defense programs, repeat Omni One Enterprise orders from Tesla’s Optimus humanoid robot program, additional enterprise sales to organizations including NASA, and a potential defense-sector acquisition target with annual revenue near the upper end of a $10–$50 million range.
Virtuix (VTIX) has sold its Omni One full-body simulation systems to the U.S. Department of Veterans Affairs for initial deployment at the Valor Center at the Detroit VA Medical Center.
The systems will be evaluated for potential use in therapeutic applications and holistic health programs within the VA, the largest integrated healthcare system in the U.S. Virtuix links this milestone to a potential pathway into the VA’s “VA Immersive” network, which has expanded to more than 145 VA facilities nationwide. The company also highlights recent Omni One deployments at Florida Gulf Coast University and Rutgers University for occupational therapy, neurological rehabilitation, and AI-assisted neurodivergent therapy, alongside growing use of its technology across multiple U.S. military branches.
Virtuix (VTIX)/b) reports approximately 3X quarter-to-date Omni One order growth versus the same period last year following its June launch for Meta Quest, and outlines advances in defense, enterprise and acquisition initiatives.Omni One orders had already risen 72% year-over-year in the first fiscal quarter, and the company believes Meta Quest integration broadens its consumer addressable market. Virtuix recorded its first contract revenue from a U.S. Air Force AFWERX SBIR Phase I award for its Virtual Terrain Walk platform and plans to seek a Phase II award, which can provide up to about $2 million in additional funding. The company is also progressing C-UAS and Infantry Fireteam training systems across U.S. military branches. In enterprise, Omni One Enterprise received repeat orders from Tesla for its Optimus robot program and new orders from Figure AI, NASA, KBR, Sirica Therapeutics and research institutions. Virtuix is in advanced talks on a potential defense acquisition with annual revenue near the upper end of a $10–$50 million target range, though completion is not assured.
Virtuix (VTIX) will showcase its recent business momentum and Omni One growth at the H.C. Wainwright 28th Annual Global Investment Conference in mid-September 2026.
The company recently reported quarterly revenue that exceeded analyst expectations by more than 50%, alongside accelerating consumer demand for its Omni One full-body simulation platform. Management plans to discuss expanding applications across defense, robotics, healthcare and enterprise markets, including Meta Quest ecosystem integration, humanoid robotics work with Tesla, Counter-UAS training for the U.S. Marine Corps, and autism therapy use cases for children.
Virtuix (VTIX) sold its first Omni One Enterprise systems to the U.S. Navy’s Morale, Welfare and Recreation (MWR) Liberty Program, with an initial deployment of two units, priced at approximately $15,000, at a U.S. Naval Station in Europe.
This is Virtuix’s first sale to the Navy’s Liberty Program and extends its military use cases from training into recreation and entertainment for Sailors. The Liberty network currently lists 68 global locations, which the company views as a potential pathway for additional deployments. The announcement also cites growing defense-sector momentum, including AFWERX SBIR Phase I funding from the U.S. Air Force, a U.S. Marine Corps infantry trainer project via KBR, and deployments or programs with the Air Force Academy, West Point, Air National Guard, Yokota Air Base, and a cooperative R&D agreement with the U.S. Navy.
Virtuix Holdings (VTIX) will showcase its AI-enabled Counter-Unmanned Aircraft System (C-UAS) Personnel Trainer to senior U.S. Army and Joint leaders at the Maneuver Warfighter Conference at Fort Moore, Georgia, on September 15-17, 2026.
Developed with partner LeadTech, the C-UAS platform uses the Omni One omni-directional treadmill to deliver full-body, immersive counter-drone marksmanship training in digital twins of real-world ranges. The system is also being evaluated by the U.S. Marine Corps Training and Education Command at Quantico. Virtuix highlights growing defense momentum, citing AFWERX SBIR Phase I funding from the U.S. Air Force, a TECOM infantry fireteam trainer program via KBR, deployments with U.S. service academies and the Air National Guard, activity at Yokota Air Base, and a cooperative research and development agreement with the U.S. Navy.
Emerging Growth Research (EGR) released an updated, company-sponsored Fiscal Q1 2027 quarterly research update on Virtuix Holdings (NASDAQ: VTIX), clarifying its paid relationship with Virtuix and related conflicts of interest. The report reviews Virtuix’s financial and operational performance, including Omni One demand and segment initiatives.
According to the update, new Omni One orders rose approximately 72% year-over-year in the fiscal first quarter and are up about 150% since the launch of Omni One for Quest, a Meta-certified product. Gross profit increased roughly 29% year-over-year, with gross margin expanding from about 17% to 30%. Virtuix ended the quarter with around $7.4 million in cash.
The report highlights ongoing expansion in defense (including the U.S. Marine Corps Infantry Fireteam Trainer, counter‑UAS training and U.S. Air Force SBIR-supported work), enterprise and robotics (such as humanoid robot teleoperation), and healthcare and NASA applications, including selection for NASA’s Moon and Mars Exploration Analog mission. EGR discloses it was paid $33,000 for this company-sponsored research and may receive additional compensation.
Emerging Growth Research reaffirmed its Buy-Emerging rating and 12‑month $9.00 price target on Virtuix (NASDAQ: VTIX), implying about 644% upside from the August 25, 2026 close of $1.21. The call follows Virtuix’s fiscal Q1 2027 revenue of $0.8 million, down 26% year-over-year from $1.0 million but above the firm’s $0.5 million estimate, driven by new orders after the June 2026 Meta partnership.
According to Emerging Growth Research, new orders rose about 72% year-over-year and about 150% since the Meta launch. Gross profit increased to $0.23 million, with gross margin expanding from 17% to about 30%, while EPS improved sequentially to $(0.22). The firm highlights access to roughly 20 million Meta Quest users, growing U.S. defense use, potential defense acquisitions in the $10–$50 million revenue range, and estimated revenue growth of about 19% in fiscal 2027 and 275% in fiscal 2028. Valuation work using 2028E peer Price/Sales and discounted cash flow yields an average value of about $8.96 per share, supporting the $9.00 target, while noting execution, defense, geopolitical, and financing risks.